Dyadic International Inc. Common Stock (DYAI)
Stock · NASDAQ · Health Care
$0.41as of 10/16/2026
Price chart
Active signals
DYAI Signal Track Record
How signals performed across all stocks →What DYAI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 54 | -5.5% | 39% | September 1, 2026 |
| Bollinger Band Breakout | 22 | -2.5% | 45% | July 21, 2026 |
| Bollinger Band Breakdown | 17 | -5.0% | 29% | August 13, 2026 |
| 200-Day Moving Average TouchActive now | 12 | -4.6% | 33% | August 12, 2026 |
| Any 20-session window (baseline) | -4.2% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About DYAI
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sect…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 5
- Website
- dyadic.com/
Fundamentals
- 1-day range
- $0.4002$0.48
- Market cap
- $37.17M
- P/E (trailing)
- —
- P/E (forward)
- -1.31
- EPS (trailing)
- $-0.23
- Dividend yield
- —
- Beta
- 1.09
- Avg. volume
- 189.3K
How Dyadic International Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 25, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
Dyadic International Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- DYAIDyadic International Inc. Common Stock$0.41▼ 2.38%Market cap $37.17MP/E —$0.3401$1.6
- ELUTElutia Inc. Class A Common Stock$0.794▲ 0.63%Market cap $38.95MP/E 0.67$0.5$1.39
- ALGSAligos Therapeutics Inc. Common Stock$4.86▼ 9.83%Market cap $34.10MP/E —$3.98$13.69
- ENGNWenGene Therapeutics Inc. Warrants$0.17▲ 1.19%Market cap $33.75MP/E —$0.1113$4.2
- TVGNTevogen Inc. Common Stock$7.07▼ 0.14%Market cap $41.58MP/E —$3.64$39
- ESLAEstrella Immunopharma Inc. Common Stock$0.43▼ 19.63%Market cap $32.10MP/E —$0.295$3.15
- QNCXQuince Therapeutics Inc. Common Stock$32.03▼ 3.61%Market cap $30.04MP/E —$15.1$910
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DYAI Dyadic International Inc. Common Stock | $37.17M | — | $0.41 | ▼ 2.38% | $0.3401$1.6 |
| ELUT Elutia Inc. Class A Common Stock | $38.95M | 0.67 | $0.794 | ▲ 0.63% | $0.5$1.39 |
| ALGS Aligos Therapeutics Inc. Common Stock | $34.10M | — | $4.86 | ▼ 9.83% | $3.98$13.69 |
| ENGNW enGene Therapeutics Inc. Warrants | $33.75M | — | $0.17 | ▲ 1.19% | $0.1113$4.2 |
| TVGN Tevogen Inc. Common Stock | $41.58M | — | $7.07 | ▼ 0.14% | $3.64$39 |
| ESLA Estrella Immunopharma Inc. Common Stock | $32.10M | — | $0.43 | ▼ 19.63% | $0.295$3.15 |
| QNCX Quince Therapeutics Inc. Common Stock | $30.04M | — | $32.03 | ▼ 3.61% | $15.1$910 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga · 10/7/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/28/2026
- Discover the top movers in Wednesday's pre-market session.ChartMill · 9/16/2026
- Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 TranscriptSeekingAlpha · 9/15/2026
- iAccess Alpha Virtual Best Ideas Fall Investment Conference Begins Today with Updated Presentation ScheduleYahoo · 9/15/2026
Insider Activity
Insider Actions →- Francisco Trust under agreement dated February 28, 1996 · July 24, 2026 · Sale2.6K @ $1.21
- Francisco Trust under agreement dated February 28, 1996 · July 23, 2026 · Sale54.8K @ $1.3
- Francisco Trust under agreement dated February 28, 1996 · July 22, 2026 · Sale38.0K @ $1.33
Institutional Ownership
March 31, 2026
- Total shares held
- 5.07M
- Total value held
- $4.15M
- Institutional holders
- 34
- Unknown1.27M
- Unknown928.2K
- Unknown888.0K
- Unknown326.2K
- Unknown313.5K
- Unknown275.4K
- Unknown110.0K
- Unknown106.6K
- Unknown97.0K
- Unknown81.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Dyadic International Included in After-Market Movers List
Dyadic International was featured in a Benzinga report highlighting health care stocks that moved during Monday's after-market session. The stock currently trades well below its analyst average target price, with a 52-week range spanning from $0.34 to $1.60. This inclusion reflects recent trading activity rather than a specific company announcement.
Dyadic International Included in After-Market Movers List. Dyadic International was featured in a Benzinga report highlighting health care stocks that moved during Monday's after-market session. The stock currently trades well below its analyst average target price, with a 52-week range spanning from $0.34 to $1.60. This inclusion reflects recent trading activity rather than a specific company announcement.